Quadcap Wealth Management, LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 2009674 Frisco, TX

Position in CRSP

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$258,901

+$28,663 QoQ

Shares Held

4,747

-1.9% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#289

of 521 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Quadcap Wealth Management, LLC holds $2,649,115 across 9 Biotechnology names. CRSP ranks #4 (9.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,895	$941,303
2	EXEL	Exelixis, Inc.	9,961	$541,978
3	GPCR	Structure Therapeutics Inc.	7,635	$409,770
4	CRSP	CRISPR Therapeutics AG This page	4,747	$258,901
5	VKTX	Viking Therapeutics, Inc.	5,758	$224,619
6	ALNY	Alnylam Pharmaceuticals, Inc.	682	$205,302
7	ANVS	Annovis Bio, Inc.	16,110	$29,964
8	OVID	Ovid Therapeutics Inc.	11,111	$29,888

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$258,901	4,747	-1.9%	Shares	Sole	2026-07-31
2026-03-31	$230,238	4,840	+25.4%	Shares	Sole	2026-05-15
2025-12-31	$202,418	3,860	-45.9%	Shares	Sole	2026-01-29
2025-09-30	$462,095	7,130	-3.3%	Shares	Sole	2025-11-14
2025-06-30	$358,476	7,370	-3.2%	Shares	Sole	2025-08-12
2025-03-31	$259,070	7,613	+2.8%	Shares	Sole	2025-05-14
2024-12-31	$291,578	7,408	-0.8%	Shares	Sole	2025-02-14
2024-09-30	$350,846	7,468	+2.7%	Shares	Sole	2024-11-12
2024-06-30	$392,760	7,272	-0.4%	Shares	Sole	2024-08-14
2024-03-31	$497,499	7,299	-22.2%	Shares	Sole	2024-05-10
2023-12-31	$587,563	9,386	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.